Ambaic, Jericka .
HRN: 20-17-47 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/08/2023
CEFUROXIME 750MG (VIAL)
07/08/2023
07/14/2023
IVT
750mg
Q8hrs
UTI, URTI
Checking Final Appropriateness
Indication: Empiric Type of Infection: Urinary TractPneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes